Bruker (BRKRP) Divestments (2013 - 2014)

Bruker (BRKRP) reported Divestments of $12.5 million for Q4 2014, up 3.31% quarter-over-quarter from $12.1 million in Q3 2014.

Bruker (BRKRP) Divestments (2013 - 2014) Analysis & Trends

Bruker has reported Divestments for 2 years, with the latest figure at $12.5 million in Q4 2014.

For the quarter ending Q4 2014, Divestments changed N/A year-over-year to $12.5 million; the trailing twelve-month figure through Dec 2014 stood at $25.3 million (up 4960.0% YoY), and the FY2015 full-year result was $200000.0, down 99.21% from the prior year.
Divestments for Q4 2014 stood at $12.5 million, up from $12.1 million in the prior quarter.
The five-year high for Divestments was $12.5 million in Q4 2014, with the low at $500000.0 in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.37 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Bruker	-	-	379.80 Mn	-

Download Data